Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated) Completed Phase 3 Trials for Flu caused by Influenza Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00616928Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years